[The relationship of vascular changes and immune status disorders in patients with diabetes mellitus type 1].
Garagan. S F SF
Key Findings
- Thymalin treatment altered absolute numbers of T‑ and B‑lymphocytes and reduced circulating immune complexes (CIC).
- Higher lymphocyte counts and lower CIC were associated with lower end‑diastolic pressure and a higher index of myocardial vitality (better subendocardial blood flow).
- The study suggests immune status may play a protective role in vascular health for type‑1 diabetes patients.
Practical Outcomes
- For biohackers, thymalin might be worth watching as a potential supplement to support vascular and immune health in diabetes, but the evidence is limited and not yet proven for general use. More rigorous trials are needed before recommending specific doses or protocols.
Summary
In a study of 86 people with type‑1 diabetes, taking a peptide mix that included thymalin seemed to change immune cell numbers and lower harmful immune complexes, which was linked to better blood flow in the heart muscle. The researchers think stronger immune markers may protect blood vessels, while the complexes could damage them.
Abstract
Immunologic status was studied in 86 patients with type-I diabetes mellitus before and after treatment with decarise, thymaline and T-activin. With the aid of ECG, phonocardiogramme, apex cardiogramme, oscillogramme, there has been calculated index of vitality of the myocardium reflecting the subendocardial bloodflow. The principal parameters characterising bodily immune status (absolute number of T- and B-lymphocytes), T-suppressors counts as well as those of circulating immune complexes (CIC) were compared to the values for subendocardial bloodflow (end-diastolic pressure, index of vitality of the myocardium). There has been established strong inverse relation between the absolute numbers of T-, B-lymphocytes, and CIC, end-diastolic pressure and index of vitality of the myocardium, this being regarded as evidence in confirmation of the guarding role of the former and damaging one of the latter (CIC) under vascular pathology in diabetes mellitus.
Study Information
pubmed
1997